APPLICATION
ANDA061741
TYPE
ANDA
ORIGINAL APPROVAL
1973-10-10
LATEST ACTION
2024-05-01
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
PROBAMPACINDiscontinued
AMPICILLIN/AMPICILLIN TRIHYDRATE EQ 3.5GM BASE/BOT, PROBENECID 1GM/BOT · FOR SUSPENSION · ORAL
Approval history
2024-05-01Labeling · Supplement 1 · standardAP
1973-10-10OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.